Insider · CIK 0001873905
Paul Peter Tak
Files at CADL (Candel Therapeutics, Inc.). First filing Dec 3, 2024, latest Sep 11, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CADL: Candel Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Candel Therapeutics, Inc. | $3.2M 280,245 shares | -71% | +156% from low-18% from high | |
| 38Weak | Candel Therapeutics, Inc. | $230k 26,172 shares | -10% | +132% from low-28% from high | |
| 51Moderate | Candel Therapeutics, Inc. | $157k 21,704 shares | -8% | +111% from low-20% from high | |
| 51Moderate | Candel Therapeutics, Inc. | $174k 21,172 shares | -7% | +130% from low-12% from high | |
| 57Moderate | Candel Therapeutics, Inc. | $223k 48,847 shares | -14% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | CADL Candel Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +125,000 | $1.55 | $194k | 393,566 | 31 d ago |
| Sep 10, 2026 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -220,866 | $11.50 | $2.5M | 172,700 | 31 d ago |
| Sep 11, 2026 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -59,379 | $10.46 | $621k | 113,321 | 31 d ago |
| Sep 10, 2026 | CADL Candel Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -125,000 | $0.00 | $0 | 1,638,968 | 31 d ago |
| Jun 25, 2025 | CADL Candel Therapeutics, Inc. | AGrant or award Common Stock | +42,826 | $4.67 | $200k | 268,566 | Jun 26, 2025 |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,772 | $8.77 | $226k | 226,140 | Mar 20, 2025 |
| Mar 19, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -400 | $9.00 | $3,601 | 225,740 | Mar 20, 2025 |
| Feb 12, 2025 | CADL Candel Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +525,000 | $0.00 | $0 | 525,000 | Feb 14, 2025 |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock | -21,704 | $7.23 | $157k | 251,912 | Jan 17, 2025 |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock | -21,172 | $8.22 | $174k | 273,616 | Jan 10, 2025 |
| Nov 29, 2024 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock | -48,847 | $4.56 | $223k | 294,788 | Dec 3, 2024 |
| Nov 21, 2024 | CADL Candel Therapeutics, Inc. | MOption exercise Common Stock | +12,900 | $1.55 | $20k | 343,635 | Nov 21, 2024 |
| Nov 21, 2024 | CADL Candel Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -12,900 | $0.00 | $0 | 1,763,968 | Nov 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.